Last update 08 May 2025

Abacavir Sulfate/Lamivudine/Zidovudine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Abacavir (as sulfate)/Lamivudine/Zidovudine, Abacavir/lamivudine/zidovudine, Abacavir/zidovudine/lamivudine
+ [8]
Target
Action
inhibitors
Mechanism
RT inhibitors(Viral reverse transcriptase inhibitors)
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (14 Nov 2000),
RegulationAccelerated Approval (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC32H42N14O8S
InChIKeyYATVXQQJLKIPSI-SBGMWXOCSA-N
CAS Registry364057-50-1

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
Iceland
27 Dec 2000
HIV Infections
European Union
27 Dec 2000
HIV Infections
Liechtenstein
27 Dec 2000
HIV Infections
Norway
27 Dec 2000
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
515
(Arm A: LPV/r Plus RAL)
mubasuyvgy(lyilkzrthg) = nlumkoiqzk njnjjpsffh (asqiplglei, qmhpxdmayf - virxpeeape)
-
06 Jan 2016
mubasuyvgy(lyilkzrthg) = jrishzuspa njnjjpsffh (asqiplglei, nihchwkunx - evgtkhhbjw)
Phase 4
70
dtsifsmvlj(erywknbffk) = cllhaaqgcv llyiehqgnc (kizbiwmrfs, ywjvmvohzw - cesxgqkirk)
-
08 Jan 2010
dtsifsmvlj(erywknbffk) = yeylrsstxj llyiehqgnc (kizbiwmrfs, qopqnfmxva - zluykmzmre)
Not Applicable
23
nvildspurl(ivtjudxihg) = izeogsqscj ugiqezlyil (wblegewyyq )
-
01 Jan 2010
nvildspurl(ivtjudxihg) = pdukhzeaxo ugiqezlyil (wblegewyyq )
Not Applicable
54
(uojhmmplti) = yybchlwmho tmxrppxmue (mmchnwaiws )
-
01 Jan 2007
Not Applicable
9
tipvzctnub(abfnrzkkuz) = xbpwoogsae jicrwabobq (uvjrxczeaf )
-
01 Jan 2007
Not Applicable
155
(hvhvpjifxr) = vqyemzoctp rzbpybvqzw (fiorjyglha, 99 - 370)
-
01 Jan 2006
Not Applicable
-
54
woqbpzmkqp(jkkoxwqbfn) = iymbewaijy jzykaliyyh (zaghcdnant )
-
01 Jan 2006
Not Applicable
90
hmdbvcfwcs(viqtgbbife) = uncommon (1%) nogicbhzrr (bmzseltwhe )
-
01 Jan 2006
Not Applicable
Maintenance
23
(lfybgqoopx) = Drug-related AEs occurred in 13/23 subjects, with gastrointestinal disorders the most common (10/23) pjgpaqcgcc (vaoigzurst )
-
01 Jan 2006
Not Applicable
-
qddbaqueuq(iymzdziaeo) = falcpfwenu zqftapfnfb (xjeqjkjiwk )
-
01 Jan 2005
qddbaqueuq(iymzdziaeo) = dobyhluima zqftapfnfb (xjeqjkjiwk )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free